Alivus Life Sciences Limited has informed the Exchange regarding a press release dated November 06, 2025, titled "Press Release - Q2 FY2026 Financials.".
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has submitted a press release dated November 06, 2025 to the stock exchange, covering its financial results for the second quarter of FY2026. The filing itself only references the press release and does not include the actual financial figures or detailed numbers. Investors would need to refer to the company's separate Q2 FY2026 results filing or the press release document for specific revenue, profit, and other financial details.
This is an administrative filing notifying the exchange about the release of quarterly results; it has no direct impact on shareholders or stock price on its own. The actual impact will depend on the numbers reported in the accompanying Q2 FY2026 results, which are not disclosed in this particular filing.